SEC FORM 4
$8,694.58
Nuo Therapeutics, Inc. (AURX)
Purchase of 7,984 shares at $1.089 per share.
Reporting Person JORDEN DAVID EMERSON · Officer Title CEO/CFO · Transaction Code P
Traded Aug 28, 2026 · Disclosed Aug 31, 2026
Source: SEC Form 4 · 0001437749-26-029257 · filed 2026-08-31 · View filing →